Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Peritoneal Neoplasms × Letrozole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 75 Polycystic Ovary Syndrome 9 Neoplasm Metastasis 5 Neoplasms, Hormone-Dependent 3 Infertility 3 Carcinoma, Lobular 3 Carcinoma, Ductal, Breast 3 Osteoporosis 2 Fallopian Tube Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Breast Neoplasms, Male 2 Advanced Breast Cancer 2 Unilateral Breast Neoplasms 1 Recurrence 1 Peritoneal Neoplasms 1 Ovarian Neoplasms 1 Osteitis Deformans 1 Obesity 1 Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Low Grade Serous Ovarian Cancer 1 Infertility, Female 1 Hereditary Sensory and Autonomic Neuropathies 1 HER2+ Breast Cancer 1 Endometrial Neoplasms 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Carcinoma In Situ 1 Breast Cancer Metastatic 1 Breast Cancer Female 1 Bone Diseases, Metabolic 1

Interventions

Carboplatin 6 Paclitaxel 5 Hyperthermic Intraperitoneal Chemotherapy 5 Bevacizumab 3 liposomal doxorubicin 2 Neoadjuvant Therapy 2 Gemcitabine 2 relacorilant 1 phenoxodiol 1 pembrolizumab 1 olaparib 1 nintedanib 1 lobaplatin 1 lanreotide 1 epothilone B 1 atezolizumab 1 Trabectedin 1 Therapeutics 1 Surgical Procedures, Operative 1 Saline Solution 1 Oxaliplatin 1 Leucovorin 1 Letrozole 1 LAIF 900 1 Hypericum extract LI 160 1 Glucose 1 Fluorouracil 1 Doxorubicin 1 Docetaxel 1 Diathermy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04111978 2025-09-29

MATAO

Swiss GO Trial Group

Phase 3 Recruiting

Fallopian Tube Neoplasms, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡